Neurocrine Biosciences, Inc. (NBIX): Are Hedge Funds Right About This Stock?

Page 2 of 2
Company Name # of Hedge Funds # of Insiders Buying # of Insiders Selling
Keryx Biopharmaceuticals (NASDAQ:KERX) 17 0 2
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) 17 0 0
Intercept Pharmaceuticals Inc (NASDAQ:ICPT) 9 0 1
Impax Laboratories Inc (NASDAQ:IPXL) 21 3 4
Pacira Pharmaceuticals Inc (NASDAQ:PCRX) 10 1 13

With the results exhibited by the aforementioned strategies, everyday investors should always watch hedge fund and insider trading sentiment, and Neurocrine Biosciences, Inc. (NASDAQ:NBIX) shareholders fit into this picture quite nicely.

Click here to learn why you should track hedge funds

Page 2 of 2